Standard BioTools Inc. (LAB) NASDAQ
0.93
+0.0021(+0.23%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.93
+0.0021(+0.23%)
Currency In USD
| Market Cap | 488.48M |
| Enterprise Value | 401.09M |
| P/E Ratio | -4.79 |
| PEG Ratio | -0.12 |
| Price/Sales Ratio | 4.2 |
| Price/Book Ratio | 0.85 |
| Enterprise/Revenue | 3.18 |
| Enterprise/EBITDA | -3.17 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -0.88 |
| Operating Margin | -1.09 |
| Return On Assets | -0.13 |
| Return On Equity | -0.18 |
| Revenue | 85.33M |
| Revenue/Share | 0.22 |
| Gross Profit | 42.54M |
| EBITDA | -94.96M |
| Net Income | -74.9M |
| Diluted EPS | -0.2 |
| Total Cash | 187.58M |
| Total Cash/Share | 0.49 |
| Total Debt | 30.83M |
| Total Debt/Equity | 0.07 |
| Current Ratio | 4.19 |
| Book Value Per Share | 1.1 |
| 52-Week Change | -15.22 |
| 52-Week High | 1.72 |
| 52-Week Low | 0.92 |
| Moving Average 50 Days | 1.28 |
| Moving Average 200 Days | 1.29 |
| Average Volume | 1.85M |
| Shares Outstanding | 384.57M |
| % Held by Institutions | 79.1 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |